Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934
Date
of Report (Date of Earliest Event Reported):
|
March
11, 2008
|
Grant
Life Sciences, Inc.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-50133
|
|
82-0490737
|
(State
or other jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
|
|
|
|
|
1787
East Ft. Union Blvd., Suite 202
Salt
Lake City, Utah
|
|
|
|
84121
|
(Address
of principal executive offices)
|
|
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
|
|
(801)
773-0878
|
Copies
to:
Gregory
Sichenzia, Esq.
Andrew
M.
Smith, Esq.
Sichenzia
Ross Friedman Ference LLP
1065
Avenue of the Americas
New
York,
New York 10018
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
On
March
11, 2008, Grant Life Sciences, Inc. (the “Company”), announced the resignation
of Doyle Judd, its Chief Financial Officer, effective immediately.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
Grant
Life Sciences, Inc.
|
|
|
|
Date:
March 14, 2008
|
By:
|
/s/
Hun-Chi Lin
|
|
Name:
Hun-Chi Lin
|
|
Title:
President and Director (principal executive
officer)
|